このアイテムのアクセス数: 320

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
j.isci.2022.105427.pdf3.16 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorYi, Renxingen
dc.contributor.authorHashimoto, Rinaen
dc.contributor.authorSakamoto, Ayakaen
dc.contributor.authorMatsumura, Yasufumien
dc.contributor.authorNagao, Mikien
dc.contributor.authorTakahashi, Kazutoshien
dc.contributor.authorTakayama, Kazuoen
dc.contributor.alternative易, 人行ja
dc.contributor.alternative橋本, 里菜ja
dc.contributor.alternative坂本, 綾香ja
dc.contributor.alternative松村, 康史ja
dc.contributor.alternative長尾, 美紀ja
dc.contributor.alternative高橋, 和利ja
dc.contributor.alternative高山, 和雄ja
dc.date.accessioned2022-11-07T00:01:47Z-
dc.date.available2022-11-07T00:01:47Z-
dc.date.issued2022-11-18-
dc.identifier.urihttp://hdl.handle.net/2433/277028-
dc.descriptioniPS細胞やオルガノイド技術を用いた新型コロナウイルス感染におけるEXOC2の機能解析. 京都大学プレスリリース. 2022-10-27.ja
dc.descriptionAn important host factor in SARS-CoV-2 infection, identified using iPS cell and organoid technology. 京都大学プレスリリース. 2022-10-31.en
dc.description.abstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an epidemic and spread rapidly all over the world. Because the analysis of host factors other than receptors and proteases has not been sufficiently performed, we attempted to identify and characterize host factors essential for SARS-CoV-2 infection using iPS cells and airway organoids (AO). Based on previous CRISPR screening and RNA-seq data, we found that exocyst complex component 2 (EXOC2) is one important host factor for SARS-CoV-2 infection. The intracellular SARS-CoV-2 nucleocapsid (N) expression level was decreased to 3.7 % and the virus copy number in cell culture medium was decreased to 1.6 % by EXOC2 knockdown. Consistently, immunostaining results showed that N protein-positive cells were significantly decreased by EXOC2 knockdown. We also found that EXOC2 knockdown downregulates SARS-CoV-2 infection by regulating IFNW1 expression. In conclusion, controlling the EXOC2 expression level may prevent SARS-CoV-2 infection and deserves further study.en
dc.language.isoeng-
dc.publisherElsevier BVen
dc.rights© 2022 The Author(s).en
dc.rightsThis is an open access article under the CC BY-NC-ND license.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectHuman iPS cellsen
dc.subjectairway organoidsen
dc.subjectSARS-CoV-2en
dc.subjectEXOC2en
dc.subjectCRISPRien
dc.subjectIFNW1en
dc.subjectCOVID-19en
dc.titleExocyst complex component 2 is a potential host factor for SARS-CoV-2 infectionen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleiScienceen
dc.identifier.volume25-
dc.identifier.issue11-
dc.relation.doi10.1016/j.isci.2022.105427-
dc.textversionpublisher-
dc.identifier.artnum105427-
dc.addressCenter for iPS Cell Research and Application (CiRA), Kyoto Universityen
dc.addressCenter for iPS Cell Research and Application (CiRA), Kyoto Universityen
dc.addressCenter for iPS Cell Research and Application (CiRA), Kyoto Universityen
dc.addressDepartment of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto Universityen
dc.addressDepartment of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto Universityen
dc.addressCenter for iPS Cell Research and Application (CiRA), Kyoto Universityen
dc.addressCenter for iPS Cell Research and Application (CiRA), Kyoto University; AMED-CREST, Japan Agency for Medical Research and Development (AMED)en
dc.identifier.pmid36310645-
dc.relation.urlhttps://www.cira.kyoto-u.ac.jp/j/pressrelease/news/221027-110000.html-
dc.relation.urlhttps://www.cira.kyoto-u.ac.jp/e/pressrelease/news/221031-000000.html-
dcterms.accessRightsopen access-
dc.identifier.eissn2589-0042-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons